No. 26 (2018), Resumos
No. 26 (2018)

Reduction of biologics in rheumatoid arthritis treatment: a systematic review and meta-analysis

Resumos
Published 2019-02-11
Leticia Breda e Vasconcelos
Universidade Estadual de Campinas
Tais Freire Galvao
Universidade Estadual de Campinas
PDF

Keywords

Rheumatoid arthritis
Biologics
Dose reduction.

How to Cite

VASCONCELOS, Leticia Breda e; GALVAO, Tais Freire. Reduction of biologics in rheumatoid arthritis treatment: a systematic review and meta-analysis. Revista dos Trabalhos de Iniciação Científica da UNICAMP, Campinas, SP, n. 26, 2019. DOI: 10.20396/revpibic262018833. Disponível em: https://econtents.sbu.unicamp.br/eventos/index.php/pibic/article/view/833. Acesso em: 29 sep. 2026.
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

This systematic review assesses the effectiveness and safety of reducing the dose of biological drugs in patients with rheumatoid arthritis at low disease activity, compared to standard dose treatment. Clinical outcomes data were collected and summarized in meta-analysis of standardized mean difference or relative risk. Most outcomes were non-significant.

PDF
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2019 Leticia Breda e Vasconcelos, Tais Freire Galvao